Parasitic Worm Vesicles Quiet Human Intestinal Cells While Live Larvae Sound the Alarm

Tiny parasitic worms capable of causing chronic human infections release microscopic molecular packages that actively suppress human intestinal cells, while live larvae provoke an aggressive inflammatory response. The research, published in Frontiers in Cellular and Infection Microbiology, sheds new light on the hidden biological warfare between the human body and the nematode parasite Strongyloides stercoralis.

How Strongyloides stercoralis Infects Hundreds of Millions Worldwide

Strongyloides stercoralis is a parasitic roundworm responsible for human strongyloidiasis, a neglected tropical disease estimated to afflict between 380 million and 600 million people globally. People typically contract the infection when skin comes into contact with contaminated soil containing infective larvae. These microscopic invaders burrow through the skin, travel through the bloodstream to the lungs, climb the respiratory tract, and get swallowed down into the small intestine where they mature into egg-laying adult females.

Unlike many other parasites, this nematode features a unique auto-infective cycle that allows it to reinfect the host repeatedly without leaving the body. This trait enables decades-long chronic infections that can remain silent until a drop in immunity triggers a life-threatening systemic spread. Scientists have long sought to understand how the parasite maintains this delicate balance with the human immune system without causing immediate destruction.

Live Larvae Trigger Intense Immune Alert While Vesicles Quiet Cell Activity

To uncover the molecular tactics at play, researchers isolated infective third-stage larvae from a clinical patient sample and examined their interactions with a human colorectal adenocarcinoma cell line known as Caco-2 cells. They tracked cellular changes over periods of 6 hours, 24 hours, and 72 hours using advanced transcriptomics to measure mRNA shifts and quantitative proteomics to measure protein alterations. The team also analyzed extracellular vesicles, which are submicron membrane-bound parcels secreted by the larvae.

The multi-omics analysis revealed starkly contrasting strategies between live worms and their secreted vesicles. When human intestinal cells encountered live Strongyloides stercoralis larvae, they launched a progressive, robust activation program that peaked at 72 hours. This response involved the upregulation of pathways tied to inflammation, immune signaling, cellular proliferation, and extracellular matrix remodeling, closely mimicking the effects of a pro-inflammatory control treatment driven by interferon-gamma.

By contrast, the extracellular vesicles released by the larvae acted much faster, inducing widespread changes within 24 hours that pointed toward suppression. Rather than sounding an immune alarm, the vesicles downregulated host pathways associated with protein metabolism, RNA biogenesis, DNA repair, and respiratory electron transport. Furthermore, pathways governing antigen presentation and immunogenic cell death were inhibited, suggesting that the vesicles might help the parasite evade immune detection during early infection stages.

What These Cellular Contrasts Mean for Chronic Disease Control

The findings demonstrate that parasite-derived extracellular vesicles do not simply mimic the presence of the whole living worm. Instead, live nematodes stimulate active defense mechanisms in intestinal tissue, while their secreted vesicles appear to dampen host cell metabolism and immune responses to foster a hospitable environment for long-term survival.

The authors acknowledge limitations in their model, notably that experiments relied on a single clinical isolate and a simplified single-cell line rather than complex human tissue with diverse immune cells. Future investigations will need to explore how these mechanisms operate alongside other cellular networks in the gut and determine how varying doses of vesicles influence human tissue integrity.

The research was published in Frontiers in cellular and infection microbiology on November 12, 2026.